Despite the excellent contribution of this work, the authors only generated hypotheses that have not been corroborated, and did not define how to obtain inhibitory molecules that have selectivity over the TIM of cancer cells without interfering with the activity of the TIM of normal cells. The gene discussed is TPI1; the disease is cancer.